Depending on how they are used, some of Novozymes’ products for the biopharma industry are within the scope of REACH and are registered as such. Novozymes' products comply with REACH.

Enzymes used as processing aid for manufacturing of excipients as to pharmaceuticals or Active Pharmaceutical Ingredient (API) are subject to REACH registration whereas the excipients and the API are not. When Novozymes’ ingredients are used as components in medical devices, they become subject to REACH registration. To secure the uninterrupted supply of our products, we ensure timely REACH registration and throughout our supply chain, we take care to meet all REACH requirements.  

Do you have a question?
Novozymes’ REACH team works with all aspects of REACH and is dedicated to answering any queries that our customers may have. If you have any questions or need our support with regards to REACH, please contact your Novozymes representative or email the REACH team at